Lin Yue

An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism

Qingjuan Ren, Shuchun Chen, Xing Chen et al. · Drug Design Development and Therapy · 2022 · 79 citations · Full text

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model

Shu Niu, Shuchun Chen, Xing Chen et al. · Frontiers in Endocrinology · 2022 · 52 citations · Full text

Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression

Xiaoyu Pan, Lin Yang, Shuqi Wang et al. · Molecular and Cellular Biochemistry · 2023 · 40 citations

Inflammation, Metabolic Syndrome, Obesity +12

Single-cell transcriptomics identifies Col1a1 and Col1a2 as hub genes in obesity-induced cardiac fibrosis

Xiaoyu Pan, Xing Chen, Qingjuan Ren et al. · Biochemical and Biophysical Research Communications · 2022 · 32 citations

Fibrosis, Functional Genomics, Cardiac Reprogramming +11

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice

Xiaoyi Chen, Shuchun Chen, Zelin Li et al. · Frontiers in Pharmacology · 2023 · 26 citations · Full text